David Faleck
Director of Inflammatory and Immune-Related Bowel Diseases · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentInflammatory and Immune-Related Bowel Diseases · New York Presbyterian Hospital
- 2015–2018
2008–2012
Research
Enterocolitis due to immune checkpoint inhibitors: a systematic review
Systematic review or meta-analysis · Gut · 2018 · 209 citations
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Journal of Clinical Oncology · 2020 · 170 citations
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
The American Journal of Gastroenterology · 2018 · 153 citations
12 papers
11 papers
- AS
9 papers
9 papers · 2 as a fellow
9 papers
8 papers
8 papers
8 papers
Clinical trials
- 2025–2027
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
- 2021–2027
Stool Transplant to Control Treatment-related Diarrhea
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center